Healthtech funding in Q1 2014

European Healthtech startup funding raised during Q1 2014.

In Q1 2014, 30 European Healthtech companies closed 30 funding rounds and raised €157M in equity funding (excluding debt and grants), up 168.3% versus Q1 2013. Debt rounds added €649k. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 6 Nov 2026.

Equity funding

€157M

+168.3% vs Q1 2013 · excl. debt & grants · +€649k debt

Funding rounds

+11.1% vs Q1 2013

Companies

Top country

Switzerland

Rank among sectors

6.2% of sector funding

Debt financing

€649k

0.4% of total

Top-10 round share

90.6%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jan	€64M	12
Feb	€70M	7
Mar	€23M	11

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q1 2014
Switzerland	€67M
France	€33M
Sweden	€20M
Israel	€18M
Finland	€4.7M
Germany	€3.1M
Russia	€2.2M
Italy	€2.0M

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q1 2014
Series D+	€98M
Other	€20M
Growth/Late	€19M
Seed	€12M
Early VC	€4.8M
Series A	€4.3M
Debt	€649k

Top deals

largest disclosed rounds in Q1 2014

Company	Stage	Date	Amount
NovImmune	Series D+	Feb 2014	€49M
uTest_Vamsi	Series D+	Jan 2014	€31M
InDex Pharmaceuticals	Other	Feb 2014	€18M
AC Immune	Series D+	Jan 2014	€18M
OrCam	Growth/Late	Mar 2014	€11M
Mendor	Growth/Late	Jan 2014	€4.7M
TytoCare	Series A	Mar 2014	€4.3M
Gamida Cell	Growth/Late	Jan 2014	€3.0M
Doctor At Work	Early VC	Mar 2014	€2.2M
Medigo	Seed	Mar 2014	€2.1M
Cellply	Seed	Mar 2014	€2.0M
X-BOLT Orthapaedics	Seed	Jan 2014	€1.8M
myTomorrows	Early VC	Feb 2014	€1.6M
Simris Alg	Seed	Jan 2014	€1.5M
Integrated Optics	Other	Jan 2014	€1.2M

View all 30 Healthtech deals in Q1 2014 →

Top investors

most active in Q1 2014, by deal count

← All 2014 Healthtech funding